Prospects for predicting the course of nodular sclerosis Hodgkin lymphoma by morphometric analysis of CD163-positive macrophages

Author:

Minaev M. S.1ORCID,Perfilova E. A.1ORCID,Diakonov D. A.1ORCID,Kuzmin A. A.2,Pavlova N. B.3,Konovalov D. M.4ORCID,Paramonov I. V.1

Affiliation:

1. Kirov Research Institute of Hematology and Blood Transfusion, Federal Medical Biological Agency

2. MedInvestGroup

3. Center of Oncology and Medical Radiology

4. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia

Abstract

Background. In present days, much attention is paid to the study of the interrelation between the macrophage/hystiocytic microenvironment and the tumor substrate in lymphoproliferative disorders.Objective. The article is devoted to the morphometric and morphological assessment of CD163-positive macrophages in nodular sclerosis Hodgkin lymphoma.Materials and methods. Formalin fixed, paraffin-embedded (FFPE) lymph node samples of 45 patients were used for the study. To identify and visualize CD163-positive cells in the test material, an immunohistochemical staining method was used.Results. The study shows that the morphometric and morphological analysis of CD163-positive cells can be an effective and promising criterion for representing them as potential predictors of the disease course. Immunohistochemical study of 45 cases using the CD163 marker revealed a difference in the nature of macrophages localization in the lymph nodes nodules. The dependence of CD163-expressing cells number on the disease course was determined.Conclusion. The data obtained can be used to stratify patients with nodular sclerosis of classical Hodgkin lymphoma into risk groups and to determine personalized approaches to treatment. Immunohistochemical determination of the CD163 marker can be used in the complex diagnosis of the causes of refractoriness to the first and subsequent lines of therapy.

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference18 articles.

1. Smirnov V.P., Romanov V.S. Clinical and morphological parallels in classic Hodgkin's lymphoma. Meditsinskiy almanakh = Medical Almanac 2017;247:91-5. (In Russ.).

2. Polyatskin I.L., Artem'va A.S., Krivolapov Yu.A. Revised WHO classification of hematopoietic and lymphoid tissue tumors, 2017 (4th edition): lymphoid tissue tumors. Arkhiv patologii = Archive of Pathology 2019;81(3):59-65. (In Russ.). DOI: 10.17116/patol20198103159.

3. Mochkin N.E., Sarzhevskiy V.O., Dubinina Yu.N. et al. Outcome of classical Hodgkin's lymphoma treatment based on high-dose chemotherapy and autologous hematopoietic stem cell transplantation: The experience in the N.I. Pirogov Russian national Medical center of Surgery. Klinicheskaya onkogematologiya. Fundamentalnye issledovaniya i klinicheskaya praktika = Clinical Oncohematology. Basic Research and Clinical Practice 2018;11(3):24-40. (In Russ.).

4. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases.Eds.: I.V Poddubnaya, V.G. Savchenko. Moscow: Buki-Vedi, 2018, 356 p. (In Russ.).

5. Jaffe E., Arber D., Campo E. et al. Hematopathology. 2nd edn. Elsevier, 2016. 1216 p.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3